Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Angiogenesis >  Src inhibitor >  KX2-391

KX2-391

Basic information Safety Supplier Related

KX2-391 Basic information

Product Name:
KX2-391
Synonyms:
  • KX 01
  • 5-[4-[2-(4-Morpholinyl)ethoxy]phenyl]-N-(phenylmethyl)-2-pyridineacetamide
  • N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
  • CS-234
  • KX2-391;KX2 391;KX2391
  • KX2-391 (KX01)
  • Tirbanibulin, KX2-391
  • Tirbanibulin
CAS:
897016-82-9
MF:
C26H29N3O3
MW:
431.53
EINECS:
200-258-5
Product Categories:
  • Inhibitors
Mol File:
897016-82-9.mol
More
Less

KX2-391 Chemical Properties

Boiling point:
680.9±55.0 °C(Predicted)
Density 
1.169
storage temp. 
Store at -20°C
solubility 
insoluble in H2O; ≥121 mg/mL in DMSO; ≥2.44 mg/mL in EtOH with gentle warming and ultrasonic
form 
Powder
pka
14.73±0.46(Predicted)
color 
White to off-white
More
Less

KX2-391 Usage And Synthesis

Uses

A synthetic, orally bioavailable small molecule and non-ATP competitive Src tyrosine kinase inhibitor with an IC50 of average 72 nM.

Uses

KX2-391 is a Src Inhibitor with efficacy against certain hepatic and leukemia cell lines.

Biological Activity

kx2-391 is a highly selective inhibitor of src kinase with ic50 value of 20nm [1].kx2-391 is a non-atp competitive inhibitor of src. it is the first inhibitor that targets src kinase within the substrate binding site. kx2-391 inhibits src catalyzed trans-phosphorylation of fak, shc, paxillin as well as src kinase autophosphorylation. kx2-391 has no effects on pdgfr, egfr, jak1, jak2 and lck demonstrating it as a selective inhibitor. it is also found to be an inhibitor of tubulin polymerization through binding to the unique confirmation on heterodimeric tubulin. in cellular assays, kx2-391 shows growth inhibition in nih3t3/c-src527f cells and syf/c-src527f cells with gi50 values of 23nm and 39nm, respectively [1, 2].since src acts as a regulator in cell proliferation survival, motility and invasiveness, kx2-391 is potent against a variety of solid tumors and many leukemia tumors. it is shown to inhibit primary tumor growth and to suppress metastasis [2].

target

Src (HuH7)

References

[1] fallah-tafti a, foroumadi a, tiwari r, et al. thiazolyl n-benzyl-substituted acetamide derivatives: synthesis, src kinase inhibitory and anticancer activities. european journal of medicinal chemistry, 2011, 46(10): 4853-4858.
[2] naing a, cohen r, dy g k, et al. a phase i trial of kx2-391, a novel non-atp competitive substrate-pocket-directed src inhibitor, in patients with advanced malignancies. investigational new drugs, 2013, 31(4): 967-973.

KX2-391Supplier

Chongqing Genco Pharmaceutical Co.,Ltd Gold
Tel
023-88654579 13637703915
Email
375097861@qq.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Jinan Trio PharmaTech Co., Ltd.
Tel
+86 (531) 88811783
Email
sales@trio-pharmatech.com (International market)
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-400-6206333 18521732826
Email
market@aladdin-e.com
More
Less